VIR Q3 2019 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$237,000+107.9% YoY

Gross Profit

-$40M-16719.8% margin

Operating Income

-$48M-20118.1% margin

Net Income

-$48M-20385.7% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

+175.6%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$38M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$423M

Total Liabilities

$703M

Stockholders' Equity

-$281M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$237,000	$114,000	+107.9%
Gross Profit	-$40M	-$30M	-33.3%
Operating Income	-$48M	-$34M	-38.8%
Net Income	-$48M	-$33M	-44.4%

Revenue Segments

Contract Revenue

$237,000100%